# Johnson & Johnson (JNJ) free cash flow: $19.31B in 2025

URL: https://funkfolio.com/stock/JNJ/free-cash-flow

> Johnson & Johnson (JNJ) free cash flow was $19.31B in fiscal 2025, up 6.9% from fiscal 2024. Year-by-year chart and table.

---

## Johnson & Johnson (JNJ) free cash flow

**Free cash flow · fiscal 2025:** $19.31B year ended Dec 31, 2025

Johnson & Johnson (JNJ) generated free cash flow of $19.31B in fiscal 2025 (the year ended December 31, 2025). That is 6.9% higher than the $18.06B of fiscal 2024. Figures as of 18 Nov 2026, 12:15 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Free cash flow, fiscal 2025:** $19.31B
- **Change on fiscal 2024:** +6.9%
- **Highest on record:** $20.19B fiscal 2021
- **Lowest on record:** $11.41B fiscal 2012
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 12:15 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Johnson & Johnson free cash flow, in more detail

Across the 19 fiscal years on record (2007–2025), the highest was $20.19B in fiscal 2021 and the lowest $11.41B in fiscal 2012.

### Free cash flow by fiscal year

### Johnson & Johnson free cash flow, year by year

Johnson & Johnson (JNJ) free cash flow by fiscal year

| Fiscal year | Free cash flow | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $19.31B | 6.9% up | Dec 31, 2025 |
| 2024 | $18.06B | 1.6% up | Dec 31, 2024 |
| 2023 | $17.78B | 3.5% up | Dec 31, 2023 |
| 2022 | $17.19B | — | Dec 31, 2022 |
| 2022 | $19.76B | 2.1% down | Jan 2, 2022 |
| 2021 | $20.19B | — | Jan 3, 2021 |
| 2019 | $19.92B | 7.5% up | Dec 29, 2019 |
| 2018 | $18.53B | 4.2% up | Dec 30, 2018 |
| 2017 | $17.78B | — | Dec 31, 2017 |
| 2017 | $15.54B | 3.5% down | Jan 1, 2017 |
| 2016 | $16.11B | — | Jan 3, 2016 |
| 2014 | $15.00B | 8.5% up | Dec 28, 2014 |
| 2013 | $13.82B | 10.9% up | Dec 29, 2013 |
| 2012 | $12.46B | — | Dec 30, 2012 |
| 2012 | $11.41B | 18.5% down | Jan 1, 2012 |
| 2011 | $14.00B | 1.4% down | Jan 2, 2011 |
| 2010 | $14.21B | — | Jan 3, 2010 |
| 2008 | $11.91B | 1.4% down | Dec 28, 2008 |
| 2007 | $12.08B | — | Dec 30, 2007 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

### How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

### Free cash flow at health care companies of similar size

Free cash flow of Johnson & Johnson and comparable companies

| Company | Free cash flow | Fiscal year |
| --- | --- | --- |
| Johnson & Johnson JNJ | $19.31B | 2025 |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/free-cash-flow) | $17.82B | 2025 |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/free-cash-flow) | $12.36B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/free-cash-flow) | $16.08B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/free-cash-flow) | $15.24B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Johnson & Johnson, figure by figure

- [Johnson & Johnson market cap](https://funkfolio.com/stock/JNJ/market-cap)
- [Johnson & Johnson revenue](https://funkfolio.com/stock/JNJ/revenue)
- [Johnson & Johnson earnings](https://funkfolio.com/stock/JNJ/earnings)
- [Johnson & Johnson earnings per share (EPS)](https://funkfolio.com/stock/JNJ/eps)
- [Johnson & Johnson P/E ratio](https://funkfolio.com/stock/JNJ/pe-ratio)
- [Johnson & Johnson P/S ratio](https://funkfolio.com/stock/JNJ/ps-ratio)
- [Johnson & Johnson P/B ratio](https://funkfolio.com/stock/JNJ/pb-ratio)
- [Johnson & Johnson operating margin](https://funkfolio.com/stock/JNJ/operating-margin)
- [Johnson & Johnson dividend](https://funkfolio.com/stock/JNJ/dividend)
- [Johnson & Johnson shares outstanding](https://funkfolio.com/stock/JNJ/shares-outstanding)
- [Johnson & Johnson total debt](https://funkfolio.com/stock/JNJ/total-debt)
- [Johnson & Johnson cash on hand](https://funkfolio.com/stock/JNJ/cash)
- [Johnson & Johnson total assets](https://funkfolio.com/stock/JNJ/total-assets)
- [Johnson & Johnson return on equity (ROE)](https://funkfolio.com/stock/JNJ/roe)
- [Johnson & Johnson return on invested capital (ROIC)](https://funkfolio.com/stock/JNJ/roic)

[Johnson & Johnson (JNJ) overview: price, valuation and scorecard](https://funkfolio.com/stock/JNJ) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Johnson & Johnson free cash flow: questions and answers

**What is Johnson & Johnson's free cash flow?**

Johnson & Johnson (JNJ) generated free cash flow of $19.31B in fiscal 2025 (the year ended December 31, 2025). That is 6.9% higher than the $18.06B of fiscal 2024.

**What are the highest and lowest free cash flow figures on record for Johnson & Johnson?**

Across the 19 fiscal years on record (2007–2025), the highest was $20.19B in fiscal 2021 and the lowest $11.41B in fiscal 2012.

**How is Johnson & Johnson's free cash flow calculated?**

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Johnson & Johnson it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: free cash flow

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- [How a DCF valuation works, and why inputs swing it](https://funkfolio.com/learn/stocks/dcf-valuation)

  A discounted cash flow (DCF) valuation estimates what a business is worth today by forecasting the cash it will produce and discounting each year's cash back at a required rate of return. Because most of the value lies far in the future, a one-point change in growth or discount rate can move the answer by a quarter.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Johnson & Johnson (JNJ) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.
